Skip to content
Axcess News – Lifestyle
Author:
IRLAB Therapeutics
IRLAB to Present Clinical and Preclinical Data at The AD/PD(TM) 2026 – 20th International Conference on Alzheimer’s & Parkinson’s Diseases
March 17, 2026
IRLAB Participates in Life Science Day in Gothenburg on March 4, 2026
March 6, 2026
IRLAB Secures Milestone Payment for First Patient Dosed in Phase Ib Study with IRL757 in Parkinson’s Disease
March 6, 2026
IRLAB Publishes Full-Year Report for The Period January – December 2025
March 5, 2026
IRLAB has Received Scientific Advisory Board Confirmation on Next Steps for Pirepemat
March 5, 2026
←
Previous Page
1
2